Haemorrhagic disorder due to unspecified circulating anticoagulants or coagulation factors

Exclusions from above levels

QC48.0 – long-term use of anticoagulants without haemorrhage
KA8F.0 – vitamin K deficiency of newborn
JA43.3 – Postpartum coagulation defects

Show allHide

04 – Diseases of the immune system
05 – Endocrine, nutritional or metabolic diseases
18 – Complications of pregnancy, childbirth or the puerperium
19 – Certain conditions originating in the perinatal period
20 – Congenital malformations, deformations or chromosomal abnormalities
22 – Injury, poisoning or certain other consequences of external causes
http://id.who.int/icd/entity/1000704511 – Human immunodeficiency virus disease
JB64.1 – Other diseases of the blood or blood-forming organs or certain disorders involving the immune mechanism complicating pregnancy, childbirth or the puerperium

Sibling codes

3B21.0 – Haemorrhage due to thrombin inhibitor other than heparin
3B21.1 – Haemorrhage due to factor Xa inhibitor
3B21.Y – Haemorrhagic disorder due to other specified circulating anticoagulants or coagulation factors

Foundation entity

Haemorrhagic disorder due to circulating anticoagulants or coagulation factors inhibitors – http://id.who.int/icd/entity/156218529

Allowed postcoordination axes

associatedWith

Part of: 3B21: Haemorrhagic disorder due to circulating anticoagulants or coagulation factors inhibitors › 03: Diseases of the blood or blood-forming organs